ArticleStem cell reports2022

Ranolazine rescues the heart failure phenotype of PLN-deficient human pluripotent stem cell-derived cardiomyocytes.

Youxu Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.